TABLE OF CONTENTS

Volume 9, Issue 1 (March 2006)

Top

Editorial

Report from Durham FREE

J W Moul

Prostate Cancer Prostatic Dis 9: 1; doi:10.1038/sj.pcan.4500863

Top

Research Highlights

Prostate News FREE

Prostate Cancer Prostatic Dis 9: 2-5; doi:10.1038/sj.pcan.4500864

Top

Reviews

PSA testing: an evolving relationship with prostate cancer screening FREE

J Constantinou and M R Feneley

Prostate Cancer Prostatic Dis 9: 6-13; advance online publication, November 29, 2005; doi:10.1038/sj.pcan.4500838

Testosterone replacement therapy for late onset hypogonadism: what is the risk of inducing prostate cancer? FREE

D C Gould and R S Kirby

Prostate Cancer Prostatic Dis 9: 14-18; advance online publication, November 1, 2005; doi:10.1038/sj.pcan.4500839

The link between obesity and prostate cancer: the leptin pathway and therapeutic perspectives FREE

R Ribeiro, C Lopes and R Medeiros

Prostate Cancer Prostatic Dis 9: 19-24; advance online publication, December 13, 2005; doi:10.1038/sj.pcan.4500844

Watchful waiting for prostate cancer: a review article FREE

G W Chodak and K S Warren

Prostate Cancer Prostatic Dis 9: 25-29; advance online publication, January 10, 2006; doi:10.1038/sj.pcan.4500857

Top

Original Articles

Enlarged prostate: A landmark national survey of its prevalence and impact on US men and their partners FREE

C G Roehrborn, L Marks and R Harkaway

Prostate Cancer Prostatic Dis 9: 30-34; advance online publication, October 18, 2005; doi:10.1038/sj.pcan.4500841

Bone mineral density changes on androgen deprivation therapy for prostate cancer and response to antiresorptive therapy FREE

S Yaturu, S DjeDjos, G Alferos and C Deprisco

Prostate Cancer Prostatic Dis 9: 35-38; advance online publication, November 8, 2005; doi:10.1038/sj.pcan.4500846

Intermittent androgen replacement for intense hypogonadism symptoms in castrated patients FREE

U Ferreira, V A Leitao, F Denardi, W E Matheus, R M Stopiglia and N R Netto Jr

Prostate Cancer Prostatic Dis 9: 39-41; advance online publication, November 8, 2005; doi:10.1038/sj.pcan.4500833

Nephrostomies in obstructive uropathy; how should hormone resistant prostate cancer patients be managed and can we predict who will benefit? FREE

M R E Harris and M J Speakman

Prostate Cancer Prostatic Dis 9: 42-44; advance online publication, January 10, 2006; doi:10.1038/sj.pcan.4500858

Frequency of impalpable prostate adenocarcinoma and precancerous conditions in Greek male population: an autopsy study FREE

K Stamatiou, A Alevizos, D Perimeni, F Sofras and E Agapitos

Prostate Cancer Prostatic Dis 9: 45-49; advance online publication, November 29, 2005; doi:10.1038/sj.pcan.4500847

Polymorphisms in the prostate-specific antigen gene promoter do not predict serum prostate-specific antigen levels in African-American men FREE

J L Beebe-Dimmer, L A Lange, J E Cain, R C Lewis, A M Ray, A V Sarma, E M Lange and K A Cooney

Prostate Cancer Prostatic Dis 9: 50-55; advance online publication, October 25, 2005; doi:10.1038/sj.pcan.4500840

Quantitative expression profile of PSGR in prostate cancer FREE

L L Xu, C Sun, G Petrovics, M Makarem, B Furusato, W Zhang, I A Sesterhenn, D G McLeod, L Sun, J W Moul and S Srivastava

Prostate Cancer Prostatic Dis 9: 56-61; advance online publication, October 18, 2005; doi:10.1038/sj.pcan.4500836

Loss of heterozygosity of M6P/IGF2R gene is an early event in the development of prostate cancer FREE

C K Hu, S McCall, J Madden, H Huang, R Clough, R L Jirtle and M S Anscher

Prostate Cancer Prostatic Dis 9: 62-67; advance online publication, November 22, 2005; doi:10.1038/sj.pcan.4500842

Novel antiproliferative flavonoids induce cell cycle arrest in human prostate cancer cell lines FREE

A Q Haddad, V Venkateswaran, L Viswanathan, S J Teahan, N E Fleshner and L H Klotz

Prostate Cancer Prostatic Dis 9: 68-76; advance online publication, November 29, 2005; doi:10.1038/sj.pcan.4500845

Reduction of QM protein expression correlates with tumor grade in prostatic adenocarcinoma FREE

G Altinok, I J Powell, M Che, K Hormont, F H Sarkar, W A Sakr, D Grignon and D J Liao

Prostate Cancer Prostatic Dis 9: 77-82; advance online publication, December 6, 2005; doi:10.1038/sj.pcan.4500848

Brn-3a neuronal transcription factor functional expression in human prostate cancer FREE

J K J Diss, D J Faulkes, M M Walker, A Patel, C S Foster, V Budhram-Mahadeo, M B A Djamgoz and D S Latchman

Prostate Cancer Prostatic Dis 9: 83-91; advance online publication, November 8, 2005; doi:10.1038/sj.pcan.4500837

Octreotide scintigraphy and Chromogranin A do not predict clinical response in patients with octreotide acetate-treated hormone-refractory prostate cancer FREE

K M Kalkner, S Acosta, O Thorsson, H Frederiksen, A Nilsson, B Gustavsson, M Elingsbo, M Stridsberg and P-A Abrahamsson

Prostate Cancer Prostatic Dis 9: 92-98; advance online publication, October 18, 2005; doi:10.1038/sj.pcan.4500843

Top

Case Report

Salvage prostate cryoablation after primary interstitial brachytherapy failure: a feasible approach FREE

V Mouraviev, B Evans and T J Polascik

Prostate Cancer Prostatic Dis 9: 99-101; advance online publication, November 29, 2005; doi:10.1038/sj.pcan.4500853

Extra navigation

.

natureevents

ADVERTISEMENT